CRISPR Cleavage Product Capture With Specific 5′ Overhangs

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for capturing nucleic acids cleaved by endonucleases, such as dA-tailing, are inefficient and non-specific, leading to unwanted ligation of both desired and undesired nucleic acids.

Innovation Solution

A method involving controlled exonuclease digestion to generate a 5'-overhang in nucleic acids, allowing for specific ligation with adaptors having complementary 5'-overhangs, thereby enhancing capture efficiency and specificity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If dA-tailing method is used to capture nucleic acids, then the capture process is simple, but the capture specificity is low and unwanted nucleic acids are also ligated

Engineering Contradiction:
Improvesimplicity of capture processVSAvoidcapture specificity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The invention creates locally different end structures on nucleic acid fragments - specifically generating 5' overhangs with defined sequences through controlled exonuclease digestion. This local structural differentiation allows specific adaptors to bind only to their complementary targets, resolving the contradiction between simple processing and high specificity by making the ligation site locally unique rather than uniformly simple.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention changes the physical-chemical parameters of nucleic acid ends by controlling exonuclease digestion to generate specific 5' overhang lengths and sequences. By adjusting digestion conditions (enzyme type, temperature, time, buffer composition), the method achieves both simplicity of operation and high capture specificity through parameter optimization.

Inventive Principle:
Principle #35Parameter changes

2Speed

If dA-tailing is used to add overhangs, then ligation is kinetically advantaged, but the method is nonspecific and all nucleic acids with accessible 3'-end are modified

Engineering Contradiction:
Improveligation kineticsVSAvoidcapture specificity
Core Design Contradiction:
SpeedVSManufacturing precision

Solution Approach 1:

The invention performs preliminary action by pre-generating specific 5' overhangs on target nucleic acids through controlled exonuclease digestion before ligation. This preliminary structuring ensures that only the intended targets possess the correct overhang configuration, so when adaptors are added, ligation occurs rapidly and specifically only at the pre-prepared sites, not at all accessible ends.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention introduces controlled exonuclease digestion as an intermediary step between nucleic acid preparation and ligation. This intermediary process acts as a selective gatekeeper that converts diverse nucleic acid ends into uniform, specific 5' overhangs, mediating between the starting material and the ligation reaction to ensure both speed and specificity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If cohesive end ligation is used, then ligation efficiency is improved, but an unwanted inserted nucleotide is added to coding sequences

Engineering Contradiction:
Improveligation efficiencyVSAvoidsequence accuracy
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention employs asymmetric overhang structures where the 5' overhang on the nucleic acid fragment is designed to be complementary to a specific sequence on the adaptor, rather than using symmetric blunt ends or universal dA-dT overhangs. This asymmetry ensures directional, sequence-specific ligation that maintains reading frame accuracy in coding sequences while achieving high ligation efficiency through cohesive end pairing.

Inventive Principle:
Principle #4Asymmetry

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves more efficient and specific capture of target nucleic acids, reducing unwanted ligation products and improving downstream analysis such as sequencing.

Implementation Method 1

contacting a double-stranded target nucleic acid having a 3'-end with a catalyst possessing 3'-5'-exonuclease activity thereby generating a first 5'-overhang at a first 5'-end and a first recessed 3'-end

Methodology Applied
Scientific Effect3'-5' exonuclease activity: Enzyme

Implementation Method 2

contacting the nucleic acid with an adaptor having a second 5'-overhang at a second 5'-end, the second 5'-overhang capable of hybridizing to the first 5'-overhang thereby forming a hybrid between the first and second 5'-overhangs

Methodology Applied
Scientific EffectHybridization: Cohesion

Implementation Method 3

linking at least one of the first 3'-end with the second 5'-end thereby capturing the target nucleic acid by forming an adapted nucleic acid

Methodology Applied
Scientific EffectLigation: Chemical Bonding

Data Source

PatentUS12416045B2Method of capturing CRISPR endonuclease cleavage products
Publication Date: 2025.09.16 CARIBOU BIOSCIENCES INC
  • US12416045B2 patent drawing
  • US12416045B2 patent drawing
  • US12416045B2 patent drawing

AI summary

The invention is a method of capturing DNA ends formed by endonuclease cleavage, such as CRISPR endonuclease cleavage, for downstream analysis including amplification and sequencing.